Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous disease with respect to presentation and clinical outcome. The prognostic value of recently identified somatic mutations has not been systematically evaluated in a phase 3 trial of treatment for AML. METHODS: We performed a mutational analy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Patel, Jay P., Gönen, Mithat, Figueroa, Maria E., Fernandez, Hugo, Sun, Zhuoxin, Racevskis, Janis, Van Vlierberghe, Pieter, Dolgalev, Igor, Thomas, Sabrena, Aminova, Olga, Huberman, Kety, Cheng, Janice, Viale, Agnes, Socci, Nicholas D., Heguy, Adriana, Cherry, Athena, Vance, Gail, Higgins, Rodney R., Ketterling, Rhett P., Gallagher, Robert E., Litzow, Mark, van den Brink, Marcel R.M., Lazarus, Hillard M., Rowe, Jacob M., Luger, Selina, Ferrando, Adolfo, Paietta, Elisabeth, Tallman, Martin S., Melnick, Ari, Abdel-Wahab, Omar, Levine, Ross L.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3545649/
https://ncbi.nlm.nih.gov/pubmed/22417203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1112304
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars